These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36918473)

  • 1. Structural mechanism of Fab domain dissociation as a measure of interface stability.
    Pomarici ND; Waibl F; Quoika PK; Bujotzek A; Georges G; Fernández-Quintero ML; Liedl KR
    J Comput Aided Mol Des; 2023 Apr; 37(4):201-215. PubMed ID: 36918473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing domain interactions within antibody Fabs with kappa and lambda light chains.
    Toughiri R; Wu X; Ruiz D; Huang F; Crissman JW; Dickey M; Froning K; Conner EM; Cujec TP; Demarest SJ
    MAbs; 2016 Oct; 8(7):1276-1285. PubMed ID: 27454112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
    J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat-induced structural changes in the Fab fragment of IgG recognized by molecular dynamics stimulation--implications for signal transduction in antibodies.
    Roterman I; Konieczny L; Stopa B; Rybarska J; Piekarska B
    Folia Biol (Krakow); 1994; 42(3-4):115-28. PubMed ID: 7641940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.
    Röthlisberger D; Honegger A; Plückthun A
    J Mol Biol; 2005 Apr; 347(4):773-89. PubMed ID: 15769469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based stability engineering of the mouse IgG1 Fab fragment by modifying constant domains.
    Teerinen T; Valjakka J; Rouvinen J; Takkinen K
    J Mol Biol; 2006 Aug; 361(4):687-97. PubMed ID: 16876195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surprisingly Fast Interface and Elbow Angle Dynamics of Antigen-Binding Fragments.
    Fernández-Quintero ML; Kroell KB; Heiss MC; Loeffler JR; Quoika PK; Waibl F; Bujotzek A; Moessner E; Georges G; Liedl KR
    Front Mol Biosci; 2020; 7():609088. PubMed ID: 33330636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between the antigen and antibody is controlled by the constant domains: normal mode dynamics of the HEL-HyHEL-10 complex.
    Adachi M; Kurihara Y; Nojima H; Takeda-Shitaka M; Kamiya K; Umeyama H
    Protein Sci; 2003 Oct; 12(10):2125-31. PubMed ID: 14500870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncovalent association of heavy and light chains of human immunoglobulins. IV. The roles of the CH1 and CL domains in idiotypic expression.
    Rinfret A; Horne C; Dorrington KJ; Klein M
    J Immunol; 1985 Oct; 135(4):2574-81. PubMed ID: 3928754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline-Dependent Antibody Paratope States and Pairing Specific V
    Fernández-Quintero ML; Kroell KB; Bacher LM; Loeffler JR; Quoika PK; Georges G; Bujotzek A; Kettenberger H; Liedl KR
    Front Immunol; 2021; 12():675655. PubMed ID: 34447370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on interaction kinetics of mutations at the VH-VL interface of Fabs depend on the structural context.
    Khalifa MB; Weidenhaupt M; Choulier L; Chatellier J; Rauffer-Bruyère N; Altschuh D; Vernet T
    J Mol Recognit; 2000; 13(3):127-39. PubMed ID: 10867708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of actively soluble antigen-binding fragment (Fab) antibody and GFP fused Fab in the cytoplasm of the engineered Escherichia coli.
    Krittanai S; Putalun W; Sakamoto S; Tanaka H; Juengwatanatrakul T; Yusakul G
    Mol Biol Rep; 2020 Jun; 47(6):4519-4529. PubMed ID: 32394307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major antigen-induced domain rearrangements in an antibody.
    Stanfield RL; Takimoto-Kamimura M; Rini JM; Profy AT; Wilson IA
    Structure; 1993 Oct; 1(2):83-93. PubMed ID: 8069628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody Fab assembly: the interface residues between CH1 and CL.
    Padlan EA; Cohen GH; Davies DR
    Mol Immunol; 1986 Sep; 23(9):951-60. PubMed ID: 3097521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
    Li Y; Li H; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refined structure of an intact IgG2a monoclonal antibody.
    Harris LJ; Larson SB; Hasel KW; McPherson A
    Biochemistry; 1997 Feb; 36(7):1581-97. PubMed ID: 9048542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin constant regions provide stabilization to the paratope and enforce epitope specificity.
    McConnell SA; Casadevall A
    J Biol Chem; 2024 Jun; 300(6):107397. PubMed ID: 38763332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The eIg technology to generate Ig-like bispecific antibodies.
    Kühl L; Aschmoneit N; Kontermann RE; Seifert O
    MAbs; 2022; 14(1):2063043. PubMed ID: 35427197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural basis of antigen-antibody recognition.
    Mariuzza RA; Phillips SE; Poljak RJ
    Annu Rev Biophys Biophys Chem; 1987; 16():139-59. PubMed ID: 2439094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VL position 34 is a key determinant for the engineering of stable antibodies with fast dissociation rates.
    Hugo N; Weidenhaupt M; Beukes M; Xu B; Janson JC; Vernet T; Altschuh D
    Protein Eng; 2003 May; 16(5):381-6. PubMed ID: 12826730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.